James Gruber
Director of Finance/CFO bij ETON PHARMACEUTICALS, INC.
Vermogen: 13 496 $ op 31-03-2024
Actieve functies van James Gruber
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ETON PHARMACEUTICALS, INC. | Director of Finance/CFO | 11-04-2022 | - |
Corporate Secretary | 11-04-2022 | - | |
Treasurer | 11-04-2022 | - |
Loopbaan van James Gruber
Eerdere bekende functies van James Gruber
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Comptroller/Controller/Auditor | - | - |
Opleiding van James Gruber
Indiana University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Director of Finance/CFO | 1 |
Corporate Secretary | 1 |
Treasurer | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ETON PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Health Technology |
- Beurs
- Insiders
- James Gruber
- Ervaring